Medical therapy for premature ejaculation  

Oleh:

Montorsi, Francesco ; Salonia, Andrea

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: The Lancet (keterangan: ada di Proquest) vol. 368 no. 9539 (Sep. 2006), page 894.

Ketersediaan

Perpustakaan FK Nomor Panggil: L01.K.2006.05 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

Premature ejaculation is one of the most prevalent male sexual dysfunctions. In today's Lancet, Jon Pryor and colleagues1 report on two large double-blind randomised studies assessing the efficacy, tolerability, and safety of dapoxetine, a short-acting, selective serotonin-reuptake inhibitor (SSRI), to be used on-demand for the treatment of premature ejaculation. Dapoxetine is the first drug specifically developed for the treatment of premature ejaculation and for which substantial data from phase III studies are now becoming available.

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali